BANK VONTOBEL/PUT/VERTEX PHARMACEUTICALS/400/0.1/20.12.24 Stock

Warrant

DE000VD3R7S9

Market Closed - Boerse Frankfurt Warrants 01:46:53 2024-07-05 pm EDT
0.74 EUR -9.76% Intraday chart for BANK VONTOBEL/PUT/VERTEX PHARMACEUTICALS/400/0.1/20.12.24
Current month-11.90%
1 month-27.45%
Date Price Change
24-07-05 0.74 -9.76%
24-07-04 0.82 -3.53%
24-07-03 0.85 0.00%
24-07-02 0.85 -2.30%
24-07-01 0.87 +3.57%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 01:46 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying VERTEX PHARMACEUTICALS INCORPORATED
IssuerLogo Issuer Vontobel Vontobel
WKN VD3R7S
ISINDE000VD3R7S9
Date issued 2024-04-09
Strike 400 $
Maturity 2024-12-20 (168 Days)
Parity 10 : 1
Emission price 2.76
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.54
Lowest since issue 0.74
Spread 0.04
Spread %5.06%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
More about the company

Ratings for Vertex Pharmaceuticals Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Vertex Pharmaceuticals Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
474.6 USD
Average target price
468.3 USD
Spread / Average Target
-1.33%
Consensus